Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study.
Adult
Aged
Aged, 80 and over
COVID-19
Cohort Studies
Coronavirus Infections
/ complications
Female
Hospitalization
/ statistics & numerical data
Humans
Hypothyroidism
/ complications
Male
Middle Aged
New York City
/ epidemiology
Pandemics
Pneumonia, Viral
/ complications
Respiration, Artificial
Retrospective Studies
Risk
Thyroid Hormones
/ therapeutic use
Treatment Outcome
COVID-19
cohort
epidemiology
hypothyroidism
outcomes
survival
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
06
2020
accepted:
10
07
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
21
10
2020
Statut:
epublish
Résumé
Coronavirus diseases (COVID-19) is associated with high rates of morbidity and mortality and worse outcomes have been reported for various morbidities. The impact of pre-existing hypothyroidism on COVID-19 outcomes remains unknown. The aim of the present study was to identify a possible association between hypothyroidism and outcomes related to COVID-19 including hospitalization, need for mechanical ventilation, and all-cause mortality. All patients with a laboratory confirmed COVID-19 diagnosis in March 2020 in a large New York City health system were reviewed. Of the 3703 COVID-19 positive patients included in present study, 251 patients (6.8%) had pre-existing hypothyroidism and received thyroid hormone therapy. Hypothyroidism was not associated with increased risk of hospitalization [Adjusted Odds Ratio (OR
Identifiants
pubmed: 33013686
doi: 10.3389/fendo.2020.00565
pmc: PMC7461836
doi:
Substances chimiques
Thyroid Hormones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
565Informations de copyright
Copyright © 2020 van Gerwen, Alsen, Little, Barlow, Naymagon, Tremblay, Sinclair and Genden.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435
pubmed: 32414646
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Clin Endocrinol (Oxf). 2005 Aug;63(2):197-202
pubmed: 16060914
J Med Virol. 2020 Jul 24;:
pubmed: 32706392
J Endocrinol Invest. 2020 Jul;43(7):1027-1031
pubmed: 32361826
JAMA. 1992 Mar 4;267(9):1244-52
pubmed: 1538563
Hum Pathol. 2007 Jan;38(1):95-102
pubmed: 16996569
South Med J. 1995 Mar;88(3):347-9
pubmed: 7886534
J Pathol. 2020 Jul;251(3):228-248
pubmed: 32418199
Thyroid. 2015 Sep;25(9):979-86
pubmed: 26177259
Clin Endocrinol (Oxf). 2005 Oct;63(4):363-5
pubmed: 16181227
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 4:80
pubmed: 9439925